Home / Stocks / JENBURPH
Back to all stocks
NSE · JENBURPH

Jenburkt Pharmaceuticals Limited (JENBURPH) Share Price

Sector: Healthcare · ISIN: INE354A01013

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#2,042
of 5,047 stocks
▼ 101W▼ 11M
Peak #2,006 · 21 Sep 2026

Operating in Healthcare, Jenburkt Pharmaceuticals Limited trades at an undemanding earnings multiple, is growing revenue modestly, and earns a healthy return on equity. Ownership as of Jun 2026.

Market Cap
416.39 Cr
P/E Ratio
11.99
P/B Ratio
2.11
ROE
17.63%
ROCE
25.11%
Dividend Yield
—
52W High
—
52W Low
—

Quarterly financials

MetricQ2 2026-27Q1 2026-27Q4 2025-26Q3 2025-26
Revenue48.32 Cr35.51 Cr44.63 Cr43.02 Cr
Net Profit10.21 Cr5.89 Cr10.85 Cr5.93 Cr
EPS23.1313.3424.5813.44
Operating Profit14.47 Cr6.90 Cr17.79 Cr8.41 Cr

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter
46.62%
Public
53.38%

PUBLIC BREAKDOWN

DII
0.12%
Individuals
44.15%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

No corporate actions on record for this stock.

Other Healthcare stocks

See all Healthcare stocks →

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs